Metabolism - Clinical and Experimental
Volume 59, Issue 9 , Pages 1372-1378, September 2010

Quercetin up-regulates paraoxonase 1 gene expression via sterol regulatory element binding protein 2 that translocates from the endoplasmic reticulum to the nucleus where it specifically interacts with sterol responsive element–like sequence in paraoxonase 1 promoter in HuH7 liver cells

  • Mamatha Garige

      Affiliations

    • Department of Biochemistry, Molecular Biology and Medicine, The George Washington University, NW, Washington, DC 20052, USA
  • ,
  • Maokai Gong

      Affiliations

    • Department of Biochemistry, Molecular Biology and Medicine, The George Washington University, NW, Washington, DC 20052, USA
  • ,
  • Ravi Varatharajalu

      Affiliations

    • Department of Biochemistry, Molecular Biology and Medicine, The George Washington University, NW, Washington, DC 20052, USA
  • ,
  • M. Raj Lakshman

      Affiliations

    • The Lipid Research Laboratory 151-T, Veterans Affairs Medical Center, NW, Washington, DC 20422, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 202 745 8330; fax: +1 202 462 2006.

Received 18 September 2009; accepted 23 December 2009.

Abstract 

We previously showed that quercetin expresses its antiatherogenic effects by up-regulating paraoxonase 1 (PON1) gene and high-density lipoprotein's protective capacity against low-density lipoprotein oxidation. In an attempt to elucidate the mechanism of action of quercetin, we have now determined the effects of quercetin on PON1 gene expression, activity, protein level, nuclear mature sterol regulatory element binding protein 2 (SREBP2) level, and its translocation from the endoplasmic reticulum to nucleus and its interaction with PON1 promoter in human HuH7 liver cells using real-time reverse transcriptase polymerase chain reaction, spectrophotometry, immunoblot, confocal microscopy, and electrophoretic mobility shift assay techniques, respectively. Quercetin (20 μmol/L) treatment increased PON1 messenger RNA by 75% (P < .02), with a concomitant 2-fold (P < .05) increase in PON1 activity accompanied by 60% (P < .01) increase in PON1 protein level. There was parallel to the 1.5- to 2.0-fold increase (P < .05) in mature SREBP2 in the cell nuclei that was verified by increased immunolocalization of the mature SREBP2 (65-kd species) in the nuclei of quercetin-treated cells by confocal microscopy. Evaluation of the binding of biotin-labeled sterol responsive element (SRE)–like element of the PON1 promoter to the nuclear extract from the 24-hour quercetin (20 μmol/L)–treated HuH7 cells by electrophoretic mobility shift assay revealed that the SREBP2 specifically binds to the SRE-like element that was abolished by prior incubation with anti-SREBP2 or significantly decreased by 200-fold molar excess of unlabeled SRE-like sequence. Based on these results, we conclude that quercetin exhibits its antiatherogenic property by eliciting the translocation of the mature SREBP2 from endoplasmic reticulum to the nucleus, where it binds to SRE-like sequence in the PON1 promoter and up-regulates PON1 gene transcription and PON1 activity.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0026-0495(09)00537-X

doi:10.1016/j.metabol.2009.12.025

Metabolism - Clinical and Experimental
Volume 59, Issue 9 , Pages 1372-1378, September 2010